Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Decision-Making in Transcatheter Edge-to-Edge Repair: Insights into Atrial Functional Mitral Regurgitation

  • Kim, Joon Bum (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2021.06.17
  • Accepted : 2021.08.05
  • Published : 2021.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

The 2020 American College of Cardiology focused update on the mitral regurgitation (MR) pathway provides an excellent summary of the decision-making trees in the treatment of severe MR, in which 2 main branches of the flowchart are suggested depending on whether MR is primary or secondary. Surgery is suggested as preferable over transcatheter edge-to-edge repair (TEER) in primary MR that needs intervention. The decision-making for secondary MR generally prioritizes TEER over surgery according to the guidelines, but further stratification is necessary based on the pathophysiologic mechanisms of MR. TEER is probably the more suitable option in secondary MR caused by left ventricular dysfunction or dilatation, given the high perceived surgical risks, despite the lack of sufficient evidence in support of overt clinical benefits from surgical therapy in these patients. In atrial functional MR associated with atrial fibrillation (AF), however, concomitant ablation of AF seems to be a desirable option, as it has been demonstrated to be a key factor leading to improved survival, reduced stroke risk, and more durable mitral and tricuspid function in patients undergoing mitral surgery. Therefore, atrial functional MR requiring intervention may be best treated by surgical therapy that combines mitral repair and AF ablation in the majority of patients. This particular issue, however, needs further research to obtain scientific evidence to guide optimal management strategies.

Keywords

References

  1. Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406. https://doi.org/10.1056/NEJMoa1009355
  2. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307-18. https://doi.org/10.1056/NEJMoa1806640
  3. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607. https://doi.org/10.1056/NEJMoa1008232
  4. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705. https://doi.org/10.1056/NEJMoa1814052
  5. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706-15. https://doi.org/10.1056/NEJMoa1816885
  6. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98. https://doi.org/10.1056/NEJMoa1103510
  7. Elbadawi A, Elgendy IY, Mohamed AH, et al. Temporal trends and outcomes of transcatheter mitral valve repair and surgical mitral valve intervention. Cardiovasc Revasc Med 2020;21:1560-6. https://doi.org/10.1016/j.carrev.2020.05.021
  8. Bonow RO, O'Gara PT, Adams DH, et al. 2020 Focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020;75:2236-70.
  9. Writing Committee Members, Otto CM, Nishimura RA, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. J Am Coll Cardiol 2021;77:450-500.
  10. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381-7. https://doi.org/10.1016/j.jacc.2004.09.073
  11. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 2016;374:344-53. https://doi.org/10.1056/NEJMoa1512913
  12. Michler RE, Smith PK, Parides MK, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2016;374:1932-41. https://doi.org/10.1056/NEJMoa1602003
  13. Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297-306. https://doi.org/10.1056/NEJMoa1805374
  14. Deferm S, Bertrand PB, Verbrugge FH, et al. Atrial functional mitral regurgitation: JACC review topic of the week. J Am Coll Cardiol 2019;73:2465-76.
  15. Kwan J, Shiota T, Agler DA, et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 2003;107:1135-40. https://doi.org/10.1161/01.CIR.0000053558.55471.2D
  16. Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol 2011;58:1474-81. https://doi.org/10.1016/j.jacc.2011.06.032
  17. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm 2017;14:e445-94. https://doi.org/10.1016/j.hrthm.2017.07.009
  18. Baldi C, Citro R, Silverio A, et al. Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment. Int J Cardiol 2019;284:50-8. https://doi.org/10.1016/j.ijcard.2018.10.055
  19. Chen J, Wang Y, Lv M, et al. Mitral valve repair and surgical ablation for atrial functional mitral regurgitation. Ann Transl Med 2020;8:1420. https://doi.org/10.21037/atm-20-2958
  20. Kim JB, Moon JS, Yun SC, et al. Long-term outcomes of mechanical valve replacement in patients with atrial fibrillation: impact of the maze procedure. Circulation 2012;125:2071-80. https://doi.org/10.1161/CIRCULATIONAHA.111.082347
  21. Yoo JS, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Impact of the maze procedure and postoperative atrial fibrillation on progression of functional tricuspid regurgitation in patients undergoing degenerative mitral repair. Eur J Cardiothorac Surg 2013;43:520-5. https://doi.org/10.1093/ejcts/ezs251
  22. Kim HJ, Kim JB, Jung SH, et al. Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery. Heart 2016;102:1206-14. https://doi.org/10.1136/heartjnl-2015-308482
  23. Kim WK, Kim HJ, Kim JB, et al. Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease. Heart 2018;104:841-8. https://doi.org/10.1136/heartjnl-2017-312249
  24. Pyo WK, Kim HJ, Kim JB, et al. Does surgical ablation of atrial fibrillation benefit patients undergoing bioprosthetic valve replacement? Semin Thorac Cardiovasc Surg 2021 Jun 6 [Epub]. https://doi.org/10.1053/j.semtcvs.2021.05.015.
  25. Kim WK, Kim HJ, Kim JB, et al. Concomitant ablation of atrial fibrillation in rheumatic mitral valve surgery. J Thorac Cardiovasc Surg 2019;157:1519-28. https://doi.org/10.1016/j.jtcvs.2018.09.023
  26. Kim WK, Kim SE, Yoo JS, et al. Impact of valve repair on mild tricuspid insufficiency in rheumatic mitral surgery. J Thorac Cardiovasc Surg 2021 Jun 2 [Epub]. https://doi.org/10.1016/j.jtcvs.2021.05.033.
  27. Ro SK, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2013;146:1092-7. https://doi.org/10.1016/j.jtcvs.2012.07.100
  28. Kim HJ, Kim JB, Kim SO, et al. A risk prediction model for operative mortality after heart valve surgery in a Korean cohort. J Chest Surg 2021;54:88-98. https://doi.org/10.5090/jcs.20.102